News items related to:
-
Advocacy in Ukraine results in drastic price reduction for HIV drug, raltegravir
The All-Ukrainian Network of People Living with HIV/AIDS (the Network) has received an official letter from Merck, dated 15 March...
-
Watching Brazil: In defence of democracy and human rights
Author: Andresa Porto – Political Scientist and member of GTPI. Now that the Brazilian government’s new party blocs have been...
-
Watching Brazil. New monthly column analyzing the impact of Bolsonaro’s politics on civil society and access to medicines
Author: Andresa Porto – Political Scientist and member of GTPI. Translated from Portuguese, original version here. This is the first...
-
Action against AbbVie. Money that could treat HIV patients ‘goes up in smoke’ in Kiev
Activists gathered outside a Kiev Court to highlight the huge amount of money being wasted on an overpriced drug, due...
-
Looking back to build on our success. Making more medicines affordable in 2019
We’re gearing up for the next, expanded phase of our campaign. We’re determined that pharmaceutical companies and governments must #TreatPeopleRight...
-
Know your HIV status, know your treatment options, and demand optimal ARVs!
The theme of the 30th World AIDS Day (1 December 2018) is ‘Know your status!’. It’s a shout out for...
-
Dr Amit Sengupta, a treatment activist who dedicated his life to universal access, dies age 60
We are deeply saddened by the loss of Dr Amit Sengupta, our friend, colleague, and an inspiring treatment activist who...
-
African civil society plans for regional collaboration in tackling intellectual property barriers
First published by KELIN. ‘This meeting gives me hope that we can build a solid movement across Eastern and Southern...
-
FAQs for women of childbearing potential and dolutegravir: Key interim considerations
A forum on the risks of preconception dolutegravir exposure has pulled together frequently asked questions (FAQs) designed to help provide...
-
“HIV treatment is not sustainable, you must involve civil society to increase access,” treatment activists in Latin America and the Caribbean tell ViiV Healthcare.
Treatment activists, representing 13 countries in the Latin America and Caribbean region (LACTA), met with ViiV Healthcare in Panama City...
-
2018 applications open! Online course on reducing barriers to essential medicines in Africa
Applications are open now for this year’s intellectual property (IP) and access to medicines online course. The course is led...
-
Unitaid investment expands our work on access to medicines
ITPC is delighted to be named one of three successful grantees of a new three year investment from Unitaid to...